NCT01206712View on ClinicalTrials.gov

Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

55116

IKFE Institute for Clinical Research and Development, Mainz

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

IKFE Institute for Clinical Research and Development

OTHER

lead

ikfe-CRO GmbH

INDUSTRY

NCT01206712 - Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter